Neuphoria extends Rights Agreement expiration to 2027
Neuphoria Therapeutics amended its Rights Agreement, extending the Final Expiration Date from Oct 27, 2026, to Oct 27, 2027. This regulatory update does not currently impact standard trading operations.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed